Sabatier, R.; Martin, J.; Vicier, C.; Guérin, M.; Monneur, A.; Provansal, M.; Tassy, L.; Tarpin, C.; Extra, J.-M.; Viret, F.;
et al. Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer. J. Clin. Med. 2021, 10, 1272.
https://doi.org/10.3390/jcm10061272
AMA Style
Sabatier R, Martin J, Vicier C, Guérin M, Monneur A, Provansal M, Tassy L, Tarpin C, Extra J-M, Viret F,
et al. Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer. Journal of Clinical Medicine. 2021; 10(6):1272.
https://doi.org/10.3390/jcm10061272
Chicago/Turabian Style
Sabatier, Renaud, Johan Martin, Cécile Vicier, Mathilde Guérin, Audrey Monneur, Magali Provansal, Louis Tassy, Carole Tarpin, Jean-Marc Extra, Frédéric Viret,
and et al. 2021. "Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer" Journal of Clinical Medicine 10, no. 6: 1272.
https://doi.org/10.3390/jcm10061272
APA Style
Sabatier, R., Martin, J., Vicier, C., Guérin, M., Monneur, A., Provansal, M., Tassy, L., Tarpin, C., Extra, J.-M., Viret, F., & Goncalves, A.
(2021). Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer. Journal of Clinical Medicine, 10(6), 1272.
https://doi.org/10.3390/jcm10061272